Association between body mass index and liver disorders:: an epidemiological study

被引:8
作者
Meier, CR
Krähenbühl, S
Schlienger, RG
Jick, H
机构
[1] Univ Basel Hosp, Dept Internal Med, Div Clin Pharmacol, Basel Pharmacoepidemiol Unit, CH-4031 Basel, Switzerland
[2] Boston Univ, Med Ctr, Boston Collaborat Drug Surveillance Program, Lexington, MA USA
[3] Univ Basel, Dept Pharm, Inst Clin Pharm, Basel, Switzerland
关键词
body mass index; obesity; liver disorders; epidemiology;
D O I
10.1016/S0168-8278(02)00298-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Cross-sectional studies showed an association between obesity and liver disorders. Information on incidence rates from epidemiological studies is scarce. Methods: To explore the association between body mass index (BMI) and incident liver disorders, we conducted a follow-up study with a nested case-control analysis using the UK-based General Practice Research Database. The study population encompassed normal weight (BMI <25 kg/m(2)), pre-obese (BMI 25-29.9 kg/m(2)) or obese (BMI greater than or equal to30 kg/m(2)) subjects aged 20-79 years, matched on age, sex and general practice attended. Results: Within the study population of 207,630 subjects, we identified 2718 cases of newly diagnosed liver disorder, of whom 1524 (56.1%) had known predisposing conditions. The incidence rates were 2.48 (95% CI 2.31-2.66)/1000 person-years (py) in normal weight, 2.91 (95% CI 2.72-3.11)/1000 py in pre-obese, and 3.83 (95% CI 3.62-4.07)/1000 py in obese subjects. In the nested case-control analysis, the adjusted odds ratio (OR) for obese, as compared to normal weight subjects, was 1.2 (95% CI 1.1-1.4). The OR for idiopathic cases (without known risk factors for liver disorders) was 1.3 (95% CI 1.1-1.6). Conclusions: The study indicates that obesity is associated with a modest increase in the incidence of newly diagnosed liver disorder. (C) 2002 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:741 / 747
页数:7
相关论文
共 30 条
[1]   Prevalence of and risk factors for hepatic steatosis in northern Italy [J].
Bellentani, S ;
Saccoccio, G ;
Masutti, F ;
Crocè, LS ;
Brandi, G ;
Sasso, F ;
Cristanini, G ;
Tiribelli, C .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (02) :112-117
[2]  
BENICHOU C, 1990, J HEPATOL, V11, P272
[3]  
BIZZARO N, 1992, ITAL J GASTROENTEROL, V24, P237
[4]   Health hazards of obesity [J].
Bray, GA .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1996, 25 (04) :907-+
[5]   Liver enzyme activity and body mass index [J].
Burns, CJ ;
Boswell, JM ;
Olsen, GW .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1996, 38 (12) :1248-1252
[6]   Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes [J].
Erbey, JR ;
Silberman, C ;
Lydick, E .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (07) :588-590
[7]   Impact of overweight on the risk of developing common chronic diseases during a 10-year period [J].
Field, AE ;
Coakley, EH ;
Spadano, JL ;
Laird, N ;
Dietz, WH ;
Rimm, E ;
Colditz, GA .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (13) :1581-1586
[8]  
GALAMBOS JT, 1978, GASTROENTEROLOGY, V74, P1191
[9]   Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test [J].
Guzzaloni, G ;
Grugni, G ;
Minocci, A ;
Moro, D ;
Morabito, F .
INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (06) :772-776
[10]   Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance [J].
James, OFW ;
Day, CP .
JOURNAL OF HEPATOLOGY, 1998, 29 (03) :495-501